Lupus therapies (Homo sapiens)
From WikiPathways
Description
No description
Please use the New WikiPathways
View approved pathways at the new wikipathways.org. This website will shutdown soon.Quality Tags
Ontology Terms
Bibliography
- Su X, Yu H, Lei Q, Chen X, Tong Y, Zhang Z, Yang W, Guo Y, Lin L; ''Systemic lupus erythematosus: pathogenesis and targeted therapy.''; Mol Biomed, 2024 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
| View all... |
| Name | Type | Database reference | Comment |
|---|---|---|---|
| ALX-0061 | Metabolite | ||
| AMG 811 | Metabolite | ||
| Atacicept | Metabolite | ||
| Autoantibodies | GeneProduct | Q785022 (Other) ![]() | |
| Belimumab | Metabolite | ||
| C1QA | GeneProduct | ENSG00000173372 (Ensembl) ![]() | |
| C1QB | GeneProduct | ENSG00000173369 (Ensembl) ![]() | |
| C1QC | GeneProduct | ENSG00000159189 (Ensembl) ![]() | |
| C2 | GeneProduct | ENSG00000166278 (Ensembl) ![]() | |
| C3 | GeneProduct | ENSG00000125730 (Ensembl) ![]() | |
| C4A | GeneProduct | ENSG00000244731 (Ensembl) ![]() | |
| C4B | GeneProduct | ENSG00000224389 (Ensembl) ![]() | |
| CD19 | GeneProduct | ENSG00000177455 (Ensembl) ![]() | |
| CD22 | GeneProduct | ENSG00000012124 (Ensembl) ![]() | |
| CD28 | GeneProduct | ENSG00000178562 (Ensembl) ![]() | |
| CD38 | GeneProduct | ENSG00000004468 (Ensembl) ![]() | |
| CD40 | GeneProduct | ENSG00000101017 (Ensembl) ![]() | |
| CD40LG | GeneProduct | ENSG00000102245 (Ensembl) ![]() | "CD40L" in source |
| CD80 | GeneProduct | ENSG00000121594 (Ensembl) ![]() | |
| CD86 | GeneProduct | ENSG00000114013 (Ensembl) ![]() | |
| CI 655064 | Metabolite | ||
| CNTO 136 | Metabolite | ||
| CTLA4-Ig | Metabolite | ||
| Dapirolizumab pegol | Metabolite | ||
| Daratumumab | Metabolite | ||
| Epratuzumab | Metabolite | ||
| Guselkumab | Metabolite | ||
| IFNG | GeneProduct | ENSG00000111537 (Ensembl) ![]() | |
| IL12A | GeneProduct | ENSG00000168811 (Ensembl) ![]() | "IL17" in source |
| IL12B | GeneProduct | ENSG00000113302 (Ensembl) ![]() | "IL17" in source |
| IL17A | GeneProduct | ENSG00000112115 (Ensembl) ![]() | "IL17" in source |
| IL17B | GeneProduct | ENSG00000127743 (Ensembl) ![]() | "IL17" in source |
| IL17C | GeneProduct | ENSG00000124391 (Ensembl) ![]() | "IL17" in source |
| IL17D | GeneProduct | ENSG00000172458 (Ensembl) ![]() | "IL17" in source |
| IL17F | GeneProduct | ENSG00000112116 (Ensembl) ![]() | "IL17" in source |
| IL23A | GeneProduct | ENSG00000110944 (Ensembl) ![]() | |
| IL23B | GeneProduct | ENSG00000113302 (Ensembl) ![]() | |
| IL25 | GeneProduct | ENSG00000166090 (Ensembl) ![]() | "IL17" in source |
| IL6 | GeneProduct | ENSG00000136244 (Ensembl) ![]() | |
| IL6R | GeneProduct | ENSG00000160712 (Ensembl) ![]() | |
| Ianalumab | Metabolite | ||
| Immune complex | GeneProduct | ||
| MEDI551 | Metabolite | ||
| MHC II | GeneProduct | ||
| MHC | GeneProduct | ||
| MS4A1 | GeneProduct | ENSG00000156738 (Ensembl) ![]() | "CD20" in source |
| Mezagitamab | Metabolite | ||
| Obinutuzumab | Metabolite | ||
| Ocrelizumab | Metabolite | ||
| Ofatumumab | Metabolite | ||
| Rituximab | Metabolite | ||
| Secukinumab | Metabolite | ||
| TCR | GeneProduct | ||
| TNFSF13B | GeneProduct | ENSG00000102524 (Ensembl) ![]() | "BAFF" in source |
| Tabalumab | Metabolite | ||
| Telitacicept | Metabolite | ||
| Tocilizumab | Metabolite | ||
| Ustekinumab | Metabolite | ||
| VAY736 | Metabolite | ||
| XmAb5871 | Metabolite |
Annotated Interactions
No annotated interactions
Saving...

